Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
Bachhav YG, Heinrich A, Kalia YN. Bachhav YG, et al. Among authors: kalia yn. Eur J Pharm Biopharm. 2013 Jun;84(2):355-64. doi: 10.1016/j.ejpb.2012.11.018. Epub 2012 Nov 30. Eur J Pharm Biopharm. 2013. PMID: 23207321
Modeling transdermal drug release.
Kalia YN, Guy RH. Kalia YN, et al. Adv Drug Deliv Rev. 2001 Jun 11;48(2-3):159-72. doi: 10.1016/s0169-409x(01)00113-2. Adv Drug Deliv Rev. 2001. PMID: 11369080 Review.
Non-invasive assessment of the effects of iontophoresis on human skin in-vivo.
Curdy C, Kalia YN, Guy RH. Curdy C, et al. Among authors: kalia yn. J Pharm Pharmacol. 2001 Jun;53(6):769-77. doi: 10.1211/0022357011776117. J Pharm Pharmacol. 2001. PMID: 11428652 Review.
Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery.
Moser K, Kriwet K, Kalia YN, Guy RH. Moser K, et al. Among authors: kalia yn. Int J Pharm. 2001 Aug 14;224(1-2):169-76. doi: 10.1016/s0378-5173(01)00762-1. Int J Pharm. 2001. PMID: 11472826
Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug.
Moser K, Kriwet K, Froehlich C, Kalia YN, Guy RH. Moser K, et al. Among authors: kalia yn. Pharm Res. 2001 Jul;18(7):1006-11. doi: 10.1023/a:1010948630296. Pharm Res. 2001. PMID: 11496937
Enhanced skin permeation of a lipophilic drug using supersaturated formulations.
Moser K, Kriwet K, Kalia YN, Guy RH. Moser K, et al. Among authors: kalia yn. J Control Release. 2001 Jun 15;73(2-3):245-53. doi: 10.1016/s0168-3659(01)00290-5. J Control Release. 2001. PMID: 11516502
Passive skin penetration enhancement and its quantification in vitro.
Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Moser K, et al. Among authors: kalia yn. Eur J Pharm Biopharm. 2001 Sep;52(2):103-12. doi: 10.1016/s0939-6411(01)00166-7. Eur J Pharm Biopharm. 2001. PMID: 11522474 Review.
Post-iontophoresis recovery of human skin impedance in vivo.
Curdy C, Kalia YN, Guy RH. Curdy C, et al. Among authors: kalia yn. Eur J Pharm Biopharm. 2002 Jan;53(1):15-21. doi: 10.1016/s0939-6411(01)00216-8. Eur J Pharm Biopharm. 2002. PMID: 11777748
Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
Marro D, Kalia YN, Delgado-Charro MB, Guy RH. Marro D, et al. Among authors: kalia yn. Pharm Res. 2001 Dec;18(12):1701-8. doi: 10.1023/a:1013318412527. Pharm Res. 2001. PMID: 11785689
Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
Marro D, Kalia YN, Delgado-Charro MB, Guy RH. Marro D, et al. Among authors: kalia yn. Pharm Res. 2001 Dec;18(12):1709-13. doi: 10.1023/a:1013370529366. Pharm Res. 2001. PMID: 11785690
147 results
Jump to page
Feedback